Publicaciones

Fecha de la publicación Título de la Publicación Primer Autor Resto de Autores Revista Factor de Impacto Artículo
2024 Use of eculizumab in pediatric patients with high-risk transplant-associated thrombotic microangiopathy: outcomes and risk factors associated with response and survival. A retrospective study on behalf of the Spanish Group for Hematopoietic Transplantatio Benítez-Carabante MI Benítez-Carabante MI, Bueno D, Alonso García L, López Torija I, Marsal J, Fernandez NavarroJM, Uria Oficialdegui ML, Panesso M, Molina B, Beléndez Bieler C, Palomo P, Pérez Martínez A, Diaz-de-Heredia C Transplant Cell Ther. 2024 Mar 21:S2666-6367(24)00292-6. doi: 10.1016/j.jtct.2024.03.019. Epub ahead of print. PMID: 38521410. 3.2 Ver artículo
2024 Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial Cabrero M Cabrero M, López-Corral L, Jarque I, de la Cruz-Vicente F, Pérez-López E, Valcárcel D, Sanz J, Espigado I, Ortí G, Martín-Calvo C, de la Serna J, Caballero D; Grupo Español de Trasplante Hematopoyético (GETH) and Grupo Español de Linfomas y Trasplante Aut Bone Marrow Transplant. 2024 Mar;59(3):359-365. doi: 10.1038/s41409-023-02171-5. Epub 2024 Jan 2. PMID: 38167647. 4.8 Ver artículo
2024 Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances Piñana JL Piñana JL, Pérez A, Chorão P, Guerreiro M, García-Cadenas I, Solano C, Martino R, Navarro D; Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) Transpl Infect Dis. 2023 Nov;25 Suppl 1:e14117. doi: 10.1111/tid.14117. Epub 2023 Aug 16. PMID: 37585370 2.6 Ver artículo
2024 SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination Piñana JL Piñana JL, Martino R, Vazquez L, López-Corral L, Pérez A, Chorão P, Avendaño-Pita A, Pascual MJ, Sánchez-Salinas A, Sanz-Linares G, Olave MT, Arroyo I, Tormo M, Villalon L, Conesa-Garcia V, Gago B, Terol MJ, Villalba M, Garcia-Gutierrez V, Cabero A, Herná Bone Marrow Transplant. 2023 May;58(5):567-580. doi: 10.1038/s41409-023-01946-0. Epub 2023 Feb 28. PMID: 36854892; PMCID: PMC9974060 4.8 Ver artículo
2024 Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials Rodríguez-Arbolí E Rodríguez-Arbolí E, Lee CJ, Caballero-Velázquez T, Martínez C, García-Calderón C, Jiménez-León MR, Bermúdez-Rodríguez MA, López-Corral L, Triguero A, Onstad L, Horwitz ME, Sarantopoulos S, Lee SJ, Pérez-Simón JA Clin Cancer Res. 2023 Oct 13;29(20):4057-4067. doi: 10.1158/1078-0432.CCR-23-0666. PMID: 37698881. 11.5 Ver artículo
2024 Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC) Galán V Galán V, Beléndez C, Echecopar C, Estival P, Sissini L, Olivas R, Bueno D, Molina B, Fuentes C, Regueiro A, Benítez I, Plaza M, Margarit A, Rifón J, Pascual A, Palomo P, Urtasun A, Fuster JL, Díaz de Heredia C, Fernández Navarro JM, González-Vicent M, Ruz Transplant Cell Ther. 2023 Nov;29(11):702.e1-702.e11. doi: 10.1016/j.jtct.2023.08.016. Epub 2023 Aug 16. PMID: 37595686 3.2 Ver artículo
2024 Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acquired Hypocellular Bone Marrow Failure Quintero V Quintero V, Bueno-Sánchez D, Mozo-Del-Castillo Y, Urtasun-Erburu A, Sisinni L, López-Duarte M, Pérez-Hurtado JM, Fuster JL, González-Vicent M, Pérez-Martínez A, Diaz-de-Heredia C; Grupo Español de Trasplante de Médula ósea en Niños (GETMON)/Grupo Español Transplant Cell Ther. 2023 Oct;29(10):621.e1-621.e6. doi: 10.1016/j.jtct.2023.07.011. Epub 2023 Jul 15. PMID: 37454760 3.2 Ver artículo
2024 Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Mar Averbuch D Averbuch D, de la Camara R, Tridello G, Knelange NS, Bykova TA, Ifversen M, Dobsinska V, Ayas M, Hamidieh AA, Pichler H, Perez-Martinez A, Cesaro S, Sundin M, Badell I, Bader P, Johansson JE, Mirci-Danicar O, Sedlacek P, Paillard C, Gibson B, Lawson S, Kr Bone Marrow Transplant. 2023 May;58(5):558-566. doi: 10.1038/s41409-023-01941-5. Epub 2023 Feb 27. PMID: 36849806; PMCID: PMC9969031. 4.8 Ver artículo
2024 Impact of SCBienvenido/aR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GETH/GETH Study Bastos-Oreiro M Bastos-Oreiro M, Gutierrez A, Iacoboni G, López Corral L, Reguera JL, Abrisqueta P, Delgado J, Terol MJ, Hernani R, Martínez N, Ortíz V, Bailen R, Gomez-Centurión I, Caballero A, Sanz J, Guerra Domínguez L, Luzardo H, Mussetti A, Jiménez-Ubieto A, Sancho Transplant Cell Ther. 2023 Dec;29(12):747.e1-747.e10. doi: 10.1016/j.jtct.2023.08.026. Epub 2023 Sep 1. PMID: 37659694. 3.2 Ver artículo
2024 Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC Fonseca-Santos M Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, García-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortés-Rodriguez M, Yañez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Español de Trasplante H Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005034. Epub ahead of print. PMID: 38685204 6.2 Ver artículo
2024 Hematopoietic stem cell transplantation in children with chronic granulomatous disease: the Spanish experience Alonso García L Alonso García L, Bueno Sánchez D, Fernández Navarro JM, Regueiro Garcia A, Blanquer Blanquer M, Benitez Carabante MI, Mozo Del Castillo Y, Fuster Soler JL, Uria Oficialdegui ML, Sisinni L, Perez Martinez A, Diaz de Heredia Rubio C Front Immunol. 2024 Feb 1;15:1307932. doi: 10.3389/fimmu.2024.1307932. PMID: 38370416; PMCID: PMC10870648 7.3 Ver artículo
2024 Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Childhood Relapsed ALL Board (ReALLNet) Moreno C Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Gonzáález Martínez B, Fuentes C, Molinos Á, Guerra-García P, Palomo P, Verdu J, Adán Pedroso RM, Vagace JM, López-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta Á, Len Front Pediatr. 2023 Mar 20;11:1140637. doi: 10.3389/fped.2023.1140637. PMID: 37020654; PMCID: PMC10067875 2.6 Ver artículo
2024 SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination Piñana JL Piñana JL, Martino R, Vazquez L, López-Corral L, Pérez A, Chorão P, Avendaño-Pita A, Pascual MJ, Sánchez-Salinas A, Sanz-Linares G, Olave MT, Arroyo I, Tormo M, Villalon L, Conesa-Garcia V, Gago B, Terol MJ, Villalba M, Garcia-Gutierrez V, Cabero A, Herná Bone Marrow Transplant. 2023 May;58(5):567-580. doi: 10.1038/s41409-023-01946-0. Epub 2023 Feb 28. PMID: 36854892; PMCID: PMC9974060 4.8 Ver artículo
2024 Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Piñana JL Piñana JL, Heras I, Aiello TF, García-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorão P, Aroca C, García-Vidal C, Arroyo I, Soler-Espejo E, López-Corral L, Avendaño-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernández-Medina L, González-Santillana C Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PMID: 37896843; PMCID: PMC10612015. 5.81 Ver artículo
2024 One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients Piñana JL Piñana JL, Vazquez L, Calabuig M, López-Corral L, Martin-Martin G, Villalon L, Sanz-Linares G, Conesa-Garcia V, Sanchez-Salinas A, Gago B, Facal A, Risco-Gálvez I, Olave MT, Espigado I, Lopez-Jimenez J, Hernández-Rivas JÁ, Avendaño-Pita A, Arroyo I, Ferre Blood Cancer J. 2023 Jan 5;13(1):8. doi: 10.1038/s41408-022-00778-3. PMID: 36599843; PMCID: PMC9812742. 12.8 Ver artículo
2023 Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study Carlos Solano Vercet Pedro Castro-Rebollo, 3 Antonio Pérez-Martínez, 4 Lucia López-Corral, 5 Pere Barba-Suñol, 6 Mi Kwon,7 Valentín Ortiz,8 Jaime Sanz-Caballer, 9 Ana Carolina Caballero,10 Joaquín Martínez,11 Ángel Cedillo,12 Anna Sureda13,14 BMJ Open 2.9 Ver artículo

Buscar